alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
CERTIFICATION



I, David J. Gallagher, Chief Financial Officer of QSound Labs, Inc. certify that:



1.

I have reviewed this annual report on Form 20-F for 2006 of QSound Labs, Inc.;



2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;



4.

The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a  15(e) and 15d  15(e)) for the company and we have:



a) designed such disclosure controls and procedures, or caused such disclosure controls and  procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;



b) evaluated the effectiveness of the companys disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosures and procedures, as of the end of the period covered by this report based on such evaluation; and



c) disclosed in this report any change in the companys internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the companys internal control over financial reporting; and



5.

The companys other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the companys auditors and the audit committee of companys board of directors (or persons performing the equivalent function):



a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the companys ability to record, process, summarize and report financial information; and



b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the companys internal control over financial reporting.









/s/ David J. Gallagher

David J. Gallagher

Chief Financial Officer





March 23, 2007
EX-10.2







Exhibit 10.2



NOTE




	 	 	 
	Date:

	 	March 2, 2011
	Maker:

	 	Claimsnet.com, Inc.
	Payee:

	 	J. R. Schellenberg
	Place for Payment:

	 	14860 Montfort Dr., Suite 250, Dallas, TX 75254
	Principal Amount:

	 	Fifteen Thousand U.S. dollars (USD$15,000.00)






Annual Interest Rate on Unpaid Principal from Date of Funding: One and three quarters percent
(1.75%)



Terms of Payment: Principal and interest shall be due and payable on demand, interest being
calculated on the unpaid principal balance to the date of each installment paid, and the payment
made credited first to the discharge of interest accrued and the balance to the reduction of the
principal. Accrued and unpaid interest shall be computed on the basis of the actual days elapsed
in a year consisting of 365 days on the principal.



Annual Interest Rate on Demanded, Unpaid Amounts: The highest rate allowed by law.



Security for Payment: None



Maker promises to pay to the order of Payee at the place for payment and according to the
terms of payment the principal amount plus interest at the rates stated above. All unpaid amounts
shall be due upon demand.



On default in the payment of this note or in the performance of any obligation in any
instrument securing or collateral to it, this note and all obligations in all instruments securing
or collateral to it shall become immediately due at the election of Payee. Maker and each surety,
endorser, and guarantor waive all demands for payment, presentations for payment, notices of
intention to accelerate maturity, notices of acceleration of maturity, protest, and notices of
protest.



If this note or any instrument securing or collateral to it is given to an attorney for
collection or enforcement, or if suit is brought for collection or enforcement, or if it is
collected or enforced through probate, bankruptcy, or other judicial proceeding, then Maker shall
pay Payee reasonable attorney’s fees in addition to other amounts due. Reasonable attorney’s fees
shall be 10.0% of all amounts due unless either party pleads otherwise.



Nothing in this note shall authorize the collection of interest in excess of the highest rate
allowed by law.



Maker reserves the right to prepay the outstanding principal balance of this Note, in whole or
in part, at any time and from time to time, without premium or penalty. Any such pre-payment shall
be made together with payment of interest accrued on the amount of principal being prepaid through
the date of such prepayment, and shall be applied to the installments of principal due hereunder in
the inverse order of maturity.



Each Maker is responsible for the entire amount of this note.



The terms Maker and Payee and other nouns and pronouns include the plural if more than one.



Maker shall not be deemed to be in default of this note unless and until Maker shall have been
given seven (7) days written notice and opportunity to cure such default, via certified mail return
receipt requested.



Claimsnet.com, Inc.



By:  /s/ Don Crosbie



Don Crosbie, CEO



MAKER
exv10ww






Exhibit 10(w)




Amendment to Nonqualified Deferred Compensation Plan for Independent Contractors




Effective January 1, 2009, Section 8.11 of the WF Deferred Compensation Holdings, Inc. Nonqualified
Deferred Compensation Plan for Independent Contractors (as Amended and Restated Effective as of
January 1, 2008) was amended in its entirety to read in full as follows:





          Section 8.11 Distribution of Small Aggregate Balances Due to Separation from Service,
Death or Plan Termination. Notwithstanding anything in this Plan to the contrary, if the
aggregate value of the Participant’s Accounts on the first date as of which benefit
payments commence due to Separation from Service, Death or Plan Termination is not greater
than the applicable dollar amount under Code §402(g)(1)(B), the Participant’s benefit shall
be paid in an immediate single lump sum. Payment shall not be permitted pursuant to this
Section 8.11 unless the payment results in the termination and liquidation of the
Participant’s entire interest under the Plan and all other arrangements that, together with
the Plan, are treated as a single plan within the meaning of Treas. Reg. §1.409A-1(c)(2),
taking into account only such interests as are subject to Code §409A.
STATE of Missouri, Respondent, v. Laura Irene STROTKAMP, Appellant.

WD 80106

Missouri Court of Appeals, Western District.

Filed: June 12, 2018

Amy M. Bartholow, Columbia for appellant.

Mary H. Moore, Jefferson City for respondent.

Before Division Two: James E. Welsh, P.J.,1 and Alok Ahuja and Anthony Rex Gabbert, JJ.

**ORDER**

1

Judge Welsh retired as an active member of this Court on April 1, 2018, after the submission of this case. He has been assigned by the Chief Justice of the Missouri Supreme Court to participate in this decision as a senior judge.

PER CURIAM:

*920After a jury trial in the Circuit Court of Henry County, Appellant Laura Strotkamp was found guilty of endangering the welfare of a child in the first degree, in violation of § 568.045, RSMo. The charges stemmed from Strotkamp's failure to obtain medical care for her fourteen-year-old son, for injuries he suffered as a result of abuse by his stepfather. Strotkamp appeals, arguing that the State presented insufficient evidence at trial that she knowingly created a substantial risk to her son's life, body or health. We affirm. Because a published opinion would have no precedential value, we have provided the parties an unpublished memorandum setting forth the reasons for this order. Rule 30.25(b).
EXHIBIT
      32.3




Written
      Statement of Principal Financial Officer Furnished Pursuant to


18
      U.S.C.
      Section 1350,


as
      Adopted by


Section
      906 of the Sarbanes-Oxley Act of 2002








In
      connection with the Quarterly Report on Form 10-QSB of HouseRaising, Inc. (the
      "Company") for the quarter ended June 30, 2006 as filed with the Securities
      and
      Exchange Commission on the date hereof (the "Report"), I, Richard A. von
      Gnechten, Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350,
      as adopted by Section 906 of the Sarbanes-Oxley Act of 2002, to the best of
      my
      knowledge, that:




(1)
      the
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and




(2)
      information contained in the Report fairly presents, in all material respects,
      the financial condition as of June 30, 2006 and results of operations for the
      quarter ended June 30, 2006 of the Company and its subsidiaries.






/s/
      Richard A. von Gnechten


------------------------


Richard
      A. von Gnechten


Chief
      Financial Officer (Principal Financial Officer)





August
      14, 2006





This
      certification accompanies this Report pursuant to Section 906 of the
      Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by
      the
      Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of
      Section 18 of the Securities Exchange Act of 1934, as amended.
#### *Harris v. Mooresville-Co-operative Creamery, Inc.*

Appeal by plaintiff from *Armstrong, J.,*in Chambers at Charlotte 19 July, 1949. Appeal dismissed 19 October, 1949, for want of merit.
Exhibit 10.3






Exhibit 10.3




FIRST AMENDMENT TO THE REGISTRATION RIGHTS AGREEMENT




This FIRST AMENDMENT (this “Amendment”), dated as of March 8, 2011, to the
Registration Rights Agreement, dated as of November 10, 2010, between Primo Water Corporation, a
Delaware corporation (the “Company”), and Culligan International Company, a Delaware
corporation (“Culligan”) (the “Registration Rights Agreement”), is made between the
Company and Culligan. Capitalized terms used in this Amendment without definition shall have the
meanings ascribed to such terms in the Registration Rights Agreement.



A. On March 8, 2011, the Company, Primo Refill Canada Corporation (the “Buyer”),
Culligan and Culligan of Canada, Ltd. (the “Seller”) entered into an Asset Purchase
Agreement (the “Second Purchase Agreement”) pursuant to which the Buyer agreed to acquire
certain assets in exchange for cash and equity securities of the Company, all as more fully
described in the Second Purchase Agreement.



B. The Seller has designated that the equity securities of the Company to be issued to the
Seller pursuant to the Second Purchase Agreement shall instead be issued directly to Culligan.



C. It is a condition to the Closing under the Second Purchase Agreement that this Agreement be
executed by the parties and delivered to the Seller on the Closing Date (as such term is defined in
the Second Purchase Agreement).



Now, therefore, the parties hereto agree as follows:



1. Definition of Registrable Securities. The definition of Registrable Securities in
Section 8 of the Registration Rights Agreement shall be amended by deleting clause (i) and
replacing it with the following clause (i):




(i) any equity securities of the Company issued to Culligan as
consideration under the Purchase Agreement or that certain Asset
Purchase Agreement, dated as of March 8, 2011, among the Company, Primo
Refill Canada Corporation, Culligan and Culligan of Canada, Ltd.



2. Confirmation of Registration Rights Agreement. Other than as expressly modified
pursuant to this Amendment, all of the terms, covenants and other provisions of the Registration
Rights Agreement are hereby ratified and confirmed and shall continue to be in full force and
effect in accordance with their respective terms.



3. References. All references to the Registration Rights Agreement (including
“hereof,” “herein,” “hereunder,” “hereby” and “this Agreement”) shall refer to the Registration
Rights Agreement as amended by this Amendment.



4. Miscellaneous. The provisions of Section 9 of the Registration Rights Agreement
shall apply to this Amendment mutatis mutandis.



[signature page follows]



 


 









 









IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first
written above.



	 	 	 	 	 
	 	

PRIMO WATER CORPORATION

 	 
	 	By:  	/s/ Mark Castaneda
 	 
	 	 	Name:  	Mark Castaneda 	 
	 	 	Title:  	Chief Financial Officer 	 
	 
	 	CULLIGAN INTERNATIONAL COMPANY

 	 
	 	By:  	/s/ Susan E. Bennett
 	 
	 	 	Name:  	Susan E. Bennett 	 
	 	 	Title:  	Senior Vice President,
General Counsel 	 
	 	 	  	
and Secretary
#### Barbara Vizcaino, Appellant, v Gordon and Thomas Companies, Inc., Respondent, and Forest Hills Nursing Home, Defendant.

[718 NYS2d 875]

In an action to recover damages for personal injuries, the plaintiff appeals from a judgment of the Supreme Court, Queens County (Kitzes, J.), entered April 14, 1999, which, upon a jury verdict, is in favor of the defendant Gordon and Thomas Companies, Inc., and against her, dismissing the complaint insofar as asserted against that defendant.

Ordered that the judgment is affirmed, with costs to the respondent.

The actions of the trial court were, in the main, directed towards focusing the proceedings on the relevant issues and clarifying facts material to the case in order to expedite the trial *(see, Sheinkerman v 3111 Ocean Parkway Assocs.,*259 AD2d 480; *Carson v New York City Health & Hosps. Corp.,*178 AD2d 265). Even if some of the conduct of the trial court was inappropriate, it did not deprive the plaintiff of a fair trial *(see, Sheinkerman v 3111 Ocean Parkway Assocs., supra).*

At the close of evidence, the trial court granted the oral ap*520plication of the defendant Forest Hills Nursing Home (hereinafter FHNH) for judgment as a matter of law dismissing the complaint insofar as asserted against it. However, no order was entered and the judgment appealed from dismisses the complaint only against the defendant Gordon and Thomas Companies, Inc. Accordingly, the plaintiffs contentions regarding FHNH are not properly before us *(see,*CPLR 5701). In any event, the court properly granted the application of FHNH for judgment as a matter of law. Viewing the evidence in the light most favorable to the plaintiff, there was no proof that FHNH created the allegedly defective condition which caused the plaintiffs injury or had actual or constructive notice of such condition *(see, Haghighi v Bailer,*240 AD2d 368).

The plaintiffs remaining contentions are without merit or do not warrant reversal. Bracken, Acting P. J., Altman, Krausman and Friedmann, JJ., concur.
STATE v. Timothy Calvin DENTON

228P19-1

Supreme Court of North Carolina.

June 14, 2019

Ann B. Petersen, Attorney at Law, Chapel Hill, For Denton, Timothy Calvin

Kathryne E. Hathcock, Assistant Attorney General, Robert S. Banks, District Attorney, For State of North Carolina *34The following order has been entered on the motion filed on the 14th of June 2019 by State of NC for Temporary Stay:

"Motion Allowed by order of the Court in conference, this the 14th of June 2019."
CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In  connection  with the Annual  Report on Form 10-K for the year ended
December 31, 2003 (the "Report") of FMS Financial Corporation (the "Company") as
filed with the Securities and Exchange  Commission on the date hereof, we, Craig
W. Yates,  President and Chief Executive  Officer,  and Channing L. Smith,  Vice
President and Chief Financial Officer,  certify,  pursuant to 18 U.S.C. ss.1350,
as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002, that:

         (1) The Report fully complies with the requirements of Section 13(a) of
the Securities Exchange Act of 1934; and

         (2) The  information  contained in the Report fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
Company.


<TABLE>
<CAPTION>
<S>                                     <C>

/s/Craig W. Yates                            /s/Channing L. Smith
-------------------------------------        ------------------------------------------
Craig W. Yates                               Channing L. Smith
President and Chief Executive Officer        Vice President and Chief Financial Officer
                                             (Principal Financial and Accounting Officer)
</TABLE>



March 25, 2004
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### National Science Foundation

In accordance with the Federal Advisory Committee Act (Pub. L. 92-463, as amended), the National Science Foundation announces the following meeting:

*Name:*                         Advisory Committee for Geosciences (1755).                    

*Dates:*                         April 15, 2009, 8:30 a.m.-5 p.m. and April 16, 2009, 8:30 a.m.-2 p.m.                    

*Place:*                         Stafford I, Room 1235, National Science Foundation, 4201 Wilson Blvd., Arlington, Virginia 22230.                    

*Type of Meeting:*                         Open.                    

*Contact Person:*                         Melissa Lane, National Science Foundation, Suite 705, 4201 Wilson Blvd., Arlington, Virginia 22230. Phone 703-292-8500.                    

*Minutes:*                         May be obtained from the contact person listed above.                    

*Purpose of Meeting:*                         To provide advice, recommendations, and oversight concerning support for research, education, and human resources development in the geosciences.                    

*Agenda:*

April 15, 2009 

Directorate activities and plans.

SODV Briefing.

Division Subcommittee Meetings.

Education & Diversity Subcommittee Meeting.

April 16, 2009 

Subcommittee Reports.

Meeting with the Director.

Action Items/Planning for Fall Meeting.

Dated: March 10, 2009.

Susanne Bolton,

Committee Management Officer.

[FR Doc. E9-5440  Filed 3-12-09; 8:45 am]

BILLING CODE 6717-01-P
IIB 

109TH CONGRESS 

2D SESSION H. R. 5347 

IN THE SENATE OF THE UNITED STATES 

SEPTEMBER 27, 2006 

Received 

NOVEMBER 13, 2006 

Read twice and referred to the Committee on Banking, Housing, and Urban 

Affairs 

AN ACT 

To reauthorize the HOPE VI program for revitalization of 

public housing projects. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


hmoore on PROD1PC60 with BILLS
2 

HR 5347 RFS

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘HOPE VI Reauthor3 ization Act of 2006’’. 

4 SEC. 2. EXTENSION OF PROGRAM. 

5 Section 24 of the United States Housing Act of 1937 

6 (42 U.S.C. 1437v) is amended— 

7 (1) in paragraph (1) of subsection (m), by 

8 striking the matter that follows ‘‘section’’ and insert9 ing the following: ‘‘such sums as may be necessary 

10 for fiscal year 2007.’’; and 

11 (2) in subsection (o), by striking ‘‘September 

12 30, 2006’’ and inserting ‘‘September 30, 2007’’. 

Passed the House of Representatives September 27, 

2006. 

Attest: KAREN L. HAAS, 

Clerk. 


hmoore on PROD1PC60 with BILLS
exv10w112






Exhibit 10.112




AMENDMENT NO. 8 TO

EMPLOYMENT AGREEMENT




     This is an amendment, dated as of March 8, 2011 (the “Amendment”) to the Employment Agreement
made as of the 1st day of March, 2000 (the “Employment Agreement”), by and between
SELECT MEDICAL CORPORATION, a Delaware corporation (the “Employer”), and ROBERT A. ORTENZIO, an
individual (the “Employee”).



Background




     Employer and Employee executed and delivered the Employment Agreement, that certain Amendment
No. 1 to the Employment Agreement, dated as of August 8, 2000, that certain Amendment No. 2 to the
Employment Agreement, dated as of February 23, 2001, that certain Amendment No. 3 to the Employment
Agreement, dated as of September 17, 2001, that certain Amendment No. 4 to the Employment
Agreement, dated as of December 10, 2004, that certain Amendment No. 5 to the Employment Agreement,
dated as of February 24, 2005, that certain Amendment No. 6 to the Employment Agreement, dated as
of December 18, 2008 and that certain Amendment No. 7 to the Employment Agreement, dated as of
November 10, 2010. Employer and Employee now desire to amend the Employment Agreement as provided
herein.



Agreement



1. Section 5.02(c) of the Employment Agreement is hereby amended and restated in its entirety to
read as follows and all references to Section 5.02(c) of the Employment Agreement shall be deleted:




     “(c) Intentionally Omitted.”


2. Except as amended hereby, the Employment Agreement shall continue in effect in accordance with
its terms.




     Please indicate your acceptance of the above Amendment by signing below in the space
indicated.



	 	 	 	 	 	 	 

	 	 	Very truly yours,	 	 
	 
	 	 	 	 	 	 
	 	 	SELECT MEDICAL CORPORATION, a 
Delaware Corporation	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Michael E. Tarvin
 

Michael E. Tarvin,
	 	 
	 

	 	 	 	Executive Vice President	 	 
	 
	 	 	 	 	 	 
	 	 	/s/ Robert A. Ortenzio	 	 
	 	 	 	 	 
	 	 	Robert A. Ortenzio